Peter Navarro
Trump administration pushing FDA to re-authorize hydroxychloroquine based on recent questionable study
[Trade advisor Peter Navarro is pushing for] a second emergency authorization for the antimalarial drug hydroxychloroquine to treat covid-19, the ...